175 related articles for article (PubMed ID: 6538003)
1. Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts.
Rizzo WB; Avigan J; Chemke J; Schulman JD
Neurology; 1984 Feb; 34(2):163-9. PubMed ID: 6538003
[TBL] [Abstract][Full Text] [Related]
2. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
[TBL] [Abstract][Full Text] [Related]
3. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
Singh I; Moser AE; Moser HW; Kishimoto Y
Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
5. Clinical variation in X-linked adrenoleukodystrophy: fatty acid and lipid metabolism in cultured fibroblasts.
Boles DJ; Craft DA; Padgett DA; Loria RM; Rizzo WB
Biochem Med Metab Biol; 1991 Feb; 45(1):74-91. PubMed ID: 2015112
[TBL] [Abstract][Full Text] [Related]
6. Physiological significance of fatty acid elongation system in adrenoleukodystrophy.
Koike R; Tsuji S; Ohno T; Suzuki Y; Orii T; Miyatake T
J Neurol Sci; 1991 Jun; 103(2):188-94. PubMed ID: 1880537
[TBL] [Abstract][Full Text] [Related]
7. Adrenoleukodystrophy. The chain shortening of erucic acid (22:1(n-9)) and adrenic acid (22:4(n-6)) is deficient in neonatal adrenoleukodystrophy and normal in X-linked adrenoleukodistrophy skin fibroblasts.
Christensen E; Grønn M; Hagve TA; Kase BF; Christophersen BO
Biochim Biophys Acta; 1989 Mar; 1002(1):79-83. PubMed ID: 2538146
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
Tsuji S; Sano-Kawamura T; Ariga T; Miyatake T
J Neurol Sci; 1985 Dec; 71(2-3):359-67. PubMed ID: 4087029
[TBL] [Abstract][Full Text] [Related]
9. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
[TBL] [Abstract][Full Text] [Related]
10. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
[TBL] [Abstract][Full Text] [Related]
11. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
Poulos A; Singh H; Paton B; Sharp P; Derwas N
Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
[TBL] [Abstract][Full Text] [Related]
12. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.
Rizzo WB; Phillips MW; Dammann AL; Leshner RT; Jennings SS; Avigan J; Proud VK
Ann Neurol; 1987 Mar; 21(3):232-9. PubMed ID: 3037987
[TBL] [Abstract][Full Text] [Related]
13. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
[TBL] [Abstract][Full Text] [Related]
14. Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy.
Singh I; Moser AE; Goldfischer S; Moser HW
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4203-7. PubMed ID: 6588384
[TBL] [Abstract][Full Text] [Related]
15. Effects of exogenous monounsaturated fatty acids on fatty acid metabolism in cultured skin fibroblasts from adrenoleukodystrophy patients.
Wilson R; Tocher DR; Sargent JR
J Neurol Sci; 1992 Jun; 109(2):207-14. PubMed ID: 1634904
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD).
Tsuji S; Ohno T; Miyatake T; Suzuki A; Yamakawa T
J Biochem; 1984 Oct; 96(4):1241-7. PubMed ID: 6520122
[TBL] [Abstract][Full Text] [Related]
17. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts.
Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y
J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027
[TBL] [Abstract][Full Text] [Related]
18. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.
Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658
[TBL] [Abstract][Full Text] [Related]
19. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
[TBL] [Abstract][Full Text] [Related]
20. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
